Clarapath

United States - Westchester, NY

• 18/11/2021
• Series B
• $32,000,000

Clarapath is a medical robotics company automating the laboratory. Our first product is focused on fully automating the microtomy station in pathology. Our vision is to innovate, standardize, and digitally transform anatomic pathology through higher quality lab medicine, more robust safety standards, increased lab throughput, while lowering laboratory costs and labor related delays.

Related People

Eric FeinsteinFounder

United States - New York City Metropolitan Area

CEO at Clarapath, a medical robotics company aimed at catalyzing change in the way pathology laboratories process biopsies. Deep experience in healthcare equity investments both as a board member and as an executive operator. A passion for healthcare/hospital services, healthcare IT, medical devices, consumer products, & general entrepreneurship, as well as deep interests in human capital & organizational behavior. Specialties in turnarounds, growth strategies; new market entries; sales channel effectiveness; business model transformation; performance planning; corporate development; investment monitoring; financial modeling; & valuation.

LinkedIn https://www.linkedin.com/in/eric-feinstein-7b35257/